Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche Venture Fund
Biotech
Enliven, Imara to merge into 1 oncology biotech
Enliven Therapeutics and Imara are set to merge by Q1 of 2023 in tandem with a Roche-backed $165 million fundraise for the new combo compnany.
Gabrielle Masson
Oct 14, 2022 11:30am
NMD pulls in $40M from Jeito-led, Roche-backed syndicate
Feb 15, 2022 7:10am
Arch Oncology scores $105M for anti-CD47 cancer med
Apr 27, 2021 3:59pm
Palladio grabs $20M to take once-discarded drug through phase 3
Sep 25, 2020 9:10am
NMD bags €38M to run orphan neuromuscular disease trials
Mar 23, 2018 6:58am
Pandion Therapeutics launches with $58M series A
Jan 18, 2018 7:00am
